Parkinson’s Dementia Trial: Does Ambroxol Work Biologically and Clinically?

Cough medicine may help some with Parkinson’s dementia: Trial

Ambroxol, a common cough medicine, may help stabilize neuropsychiatric symptoms in Parkinson’s disease dementia (PDD) and shows cognitive promise for patients with mutations in the GBA1 gene, according to results from a Phase 2 clinical trial. While ambroxol is widely used in Europe to treat respiratory conditions, it’s not approved in Canada or the U.S. Because it increases the activity of the enzyme beta-glucocerebrosidase (GCase), which is of…

Parkinson’s Dementia Trial: Does Ambroxol Work Biologically and Clinically?

The post Parkinson’s Dementia Trial: Does Ambroxol Work Biologically and Clinically? appeared first on European Medical Journal.